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Moraxella catarrhalis is a gram-negative bacterium that is mainly responsible for respiratory tract infections.
In this study we report a novel outer membrane protein (OMP), designated M35, with a molecular mass of 36.1
kDa. This protein was structurally homologous to classic gram-negative porins, such as OMP C from Esche-
richia coli and OMP K36 from Klebsiella pneumoniae, with a predicted structure of 8 surface loops and 16
antiparallel -sheets. The DNA sequences of the genes from 18 diverse clinical isolates showed that the gene
was highly conserved (99.6 to 100% of nucleotides), with only one isolate (ID78LN266) having base variations
that resulted in amino acid substitutions. Electrophoresis and analysis of recognition of the protein using
mouse anti-M35 sera showed that M35 was expressed on the bacterial surface and constitutively expressed
across M. catarrhalis isolates, with only ID78LN266 showing poor antibody recognition. Our results showed
that the single amino acid mutation in loop 3 significantly affected antibody recognition, indicating that loop
3 appeared to contain an immunodominant B-cell epitope. The antibody specificity to loop 3 may be a potential
mechanism for evasion of host immune responses targeted to M35, since loop 3 should theoretically orientate
into the porin channel. Thus, M35 is a highly conserved, surface-expressed protein that is of significance for
its potential functional role as an M. catarrhalis porin and is of interest as a vaccine candidate.
Moraxella catarrhalis, a gram-negative bacterium, is predom-
inantly responsible for respiratory tract infections, such as oti-
tis media, sinusitis, and exacerbations of chronic obstructive
pulmonary disease (17, 24, 30). On rare occasions, it can also
cause more serious diseases, such as meningitis and septicemia,
although these occur mainly in immunocompromised popula-
tions and neonates (7, 23). M. catarrhalis pathogenesis and
virulence factors are not well understood. For a long time,
limited research was undertaken on this bacterium, since it was
considered a normal commensal. The acceptance of M. ca-
tarrhalis as a pathogen, and its remarkably rapid development
of resistance to -lactam antibiotics (12, 14), have stimulated
research into the pathogenesis of infection and characteriza-
tion of the bacterium.
The majority of research into M. catarrhalis has been focused
on the identification and characterization of outer membrane
proteins (OMP), with a view to assessing their suitability as
vaccine antigens. An ideal vaccine candidate should be highly
conserved so that it can elicit an immune response that pro-
tects against all strains of the bacterium. A number of potential
vaccine candidates have been identified so far, and one partic-
ular characteristic of these is conservation across strains. Two
proteins that demonstrate potential as vaccine antigens, OMP
E and OMP CD, appear to be well conserved (24–26) and
demonstrate some similarity with porins from Escherichia coli
and Pseudomonas species, respectively (24). This study reports
the characterization of a novel OMP from M. catarrhalis, des-
ignated M35, that we identified as part of a search for vaccine
antigens (unpublished data). The protein has a predicted struc-
tural homology with known porins from other species and is
constitutively expressed and genetically well conserved. This
study is the first to report the identification and characteriza-
tion of a protein from M. catarrhalis that fits the classic bacte-
rial porin structure.
MATERIALS AND METHODS
Bacterial isolates and growth conditions. The Moraxella catarrhalis bacterial
isolates used in this study are listed in Table 1. Isolate K65 was used for all
aspects unless stated otherwise. Bacteria were grown overnight at 37°C with 5%
CO2 on chocolate blood agar (brain heart infusion agar supplemented with 5%
partially lysed horse blood) unless stated otherwise.
Nucleotide sequencing. Genomic DNA was extracted from each of the 21
isolates (Table 1) with the QIAGEN Genomic Tip 100/G kit, following the
manufacturer’s instructions. PCR amplification of the M35 gene was then per-
formed using the following oligonucleotide primers: 5-GGCGCATGCAAAAA
ACTTGCTCTAGCAACCGCA-3 and 5-GGCCTGCAGGAATTTATATTCT
AAACCTGCG-3. These primers contain restriction enzyme sites that were not
necessary for, but did not interfere with, this procedure (underlined). PCR was
conducted using the polymerase Pfu Turbo (Stratagene) with an initial denatur-
ing for 2 min at 95°C, 32 cycles of denaturing for 1 min at 95°C, annealing for 1
min at 50°C, and elongation for 1.5 min at 72°C, followed by 10 min at 72°C. The
resulting PCR products were purified to remove primers and unincorporated
nucleotides using the MinElute gel extraction kit (QIAGEN), following the
manufacturer’s instructions. The purified PCR products were then used as tem-
plate DNA in a dye terminator cycle sequencing reaction using the DTCS
Quick-Start Mix (Beckman Coulter), following the manufacturer’s instructions.
A sequence was determined for each isolate with each of the primers shown in
Table 2. The nucleotide sequences were then determined using the CEQ 8000
genetic analysis system (Beckman Coulter). The primers were designed to enable
sequencing of the gene (1,077 bp including stop codon) in three overlapping
sections on both strands. The sequences of each of the overlapping sections were
then pieced together manually, and the complementary sequences were com-
pared to check the integrity of the results. The sequences from each of the 21
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isolates were then compared by alignment, and any differences from the consen-
sus were noted and confirmed by repeating the above protocol.
Production of recombinant M35 protein. A recombinant polyhistidine (six-
His)-tagged form of the mature M35 protein (rM35) was created by cloning the
amplified gene into a pQE30 plasmid (clones developed previously by Sara
Gomez Gallego), expressed in Escherichia coli M15 pREP4 cells (Stratagene),
and purified using a nickel-nitrilotriacetic acid immobilized-metal affinity chro-
matography technique. The first 20 residues of the translated amino acid se-
quence are predicted to be a leader peptide that is cleaved during the assembly
of the mature protein, which is typical of bacterial outer membrane proteins. The
cleavage site was predicted to be after the sequence AQA, and N-terminal amino
acid sequencing confirmed this. The rM35 protein was therefore designed to not
contain this leader peptide.
E. coli clones were grown overnight at 37°C on Luria-Bertani (LB) medium
containing 50 g/ml of both ampicillin and kanamycin (Amresco). Single colo-
nies were then grown in LB broth culture with the same concentration of
antibiotics at 37°C in an orbital shaker to a relative optical density of approxi-
mately 0.7 at 600 nm. Expression of rM35 was then induced by the addition of
isopropyl--D-thiogalactopyranoside to a final concentration of 1 mM. Expres-
sion of the protein was allowed to occur over the next 4 h (under the same culture
conditions) before harvesting of the cells by centrifugation at 4,000  g for 20
min at 4°C. The pellets were stored at80°C overnight before purification of the
six-His-tagged protein using a nickel-nitrilotriacetic acid protein purification kit
(QIAGEN), following the manufacturer’s instructions, under denaturing condi-
tions (8 M urea).
Production of recombinant M35 protein lacking the third external loop. A
recombinant form of the M35 protein lacking the third external loop (rM35-L3)
was constructed. Two PCR products were created using the following primer
pairs: 5-GGCGCATGCAAAAAACTTGCTCTAGCAACCGCA-3 and 5-GG
CGAATTCACCAGCCAACAATGTGCCGTATT-3; and 5-GGCGAATTCA
ACAATGCCTTTGCTTATGTATC-3 and 5-GGCCTGCAGGAATTTATAT
TCTAAACCTGCG-3. These products were copies of the M35 gene from
nucleotides 4 to 348 and 445 to 1074 (does not include start or stop codon), and
EcoRI restriction sites were introduced at the end of the first product and
beginning of the second. These two PCR products were then digested with
EcoRI and ligated with T4 ligase. The pQE30 plasmid and this product were
then digested with PstI and SphI restriction enzymes, and the altered gene was
ligated into the plasmid. The plasmid was then heat shock transformed into M15
pREP4 E. coli cells, and the method outlined above was used to express and
purify the altered protein.
Polyclonal hyperimmune anti-M35 mouse serum. Hyperimmune antiserum
was raised against the recombinant M35. A solution of the protein was diluted
with sterile phosphate-buffered saline (PBS) and emulsified with an equal vol-
ume of incomplete Freund’s adjuvant (Sigma Chemicals). Adult male BALB/c
mice received 10 g of rM35 in a 100-l volume by intraperitoneal injection with
a 26-gauge needle on days 0, 7, and 14. On day 21, blood was collected for serum.
The sera from four mice were pooled, aliquoted, and stored at 20°C until
required. Mouse antiserum was generated with the approval of the University of
Canberra Animal Ethics Committee.
Flow cytometry.M. catarrhalis cells (isolates K65 and ID78LN266) were grown
overnight, harvested, and washed by centrifugation in sterile PBS. To reduce
non-M35-specific binding, the serum from both immunized and nonimmunized
mice was adsorbed against E. coli cells for 30 min at 37°C and then overnight at
4°C. M. catarrhalis cells were pelleted by centrifugation at 13,600  g for 1 min,
the supernatant was removed, and the bacteria were resuspended in 1 ml of a
1-in-50 dilution of mouse serum (immune or nonimmune) in sterile PBS and
incubated for 1 h at 37°C. The cells were again pelleted by centrifugation at
13,600  g for 1 min, the supernatant was removed, and the cells were resus-
TABLE 1. M. catarrhalis strains used in this study
Isolate designation Origin and other notesa
ATCC 25240 ......................................................................................Standard laboratory strain; American Type Culture Collection
K65 ......................................................................................................Sputum; adult; Perth, WA, 1985; penicillin sensitive
K114 ....................................................................................................Sputum; adult; Perth, WA, 1985; produces -lactamase; piliate
4223 .....................................................................................................Middle ear fluid; child with otitis media; Buffalo, New York
K65NCb...............................................................................................Nonclumping variant of K65
K114NC ..............................................................................................Nonclumping variant of K114
4223NC ...............................................................................................Nonclumping variant of 4223
8314 .....................................................................................................Nasopharyngeal swab; baby (24 days) with no otitis media evident; NT, 1992
8354 .....................................................................................................Nasopharyngeal swab; baby (30 days) with otitis media with effusion; NT, 1992
8361 .....................................................................................................NT
8402 .....................................................................................................NT
8423 .....................................................................................................Nasopharyngeal swab; baby (26 days) with otitis media with effusion; NT, 1992
8596 .....................................................................................................Nasopharyngeal swab; baby (20 days) with otitis media with effusion; NT, 1993
8724 .....................................................................................................Nasopharyngeal swab; baby (21 days) with no otitis media evident; NT, 1993
9170 .....................................................................................................NT
9315 .....................................................................................................Nasopharyngeal swab; baby (47 days) with otitis media with effusion; NT, 1994
ID 002 LN 010...................................................................................Nasopharyngeal swab; infant (2 years); Kalgoorlie, WA
ID 3 LN 259.......................................................................................Nasopharyngeal swab; infant (2 years); Kalgoorlie, WA
ID 23 LN 175.....................................................................................Nasopharyngeal swab; infant (2 years); Kalgoorlie, WA
ID 60 LN 148.....................................................................................Nasopharyngeal swab; infant (2 years); Kalgoorlie, WA
ID 78 LN 266.....................................................................................Nasopharyngeal swab; infant (2 years); Kalgoorlie, WA
a WA, Western Australia; NT, Northern Territory.
b Further information on the generation of the nonclumping variants can be found in reference 19.
TABLE 2. Primers used for DNA sequencing
Primer designation Position and primer sequence
SGp35pQF ..................................................................................................................... 1 GGCGCATGCAAAAAACTTGCTCTAGCAACCGCA
M35F1 ............................................................................................................................ 298 GATACTTACCTAGGTCTTGC
M35F2 ............................................................................................................................ 738 GTCTGAGGGCAAGGTAGGCG
M35F3 ............................................................................................................................ 10 CTTGCTCTAGCAACCGCAG
SGp35pQR..................................................................................................................... 1077 GGCCTGCAGGAATTTATATTCTAAACCTGCG
M35R1............................................................................................................................ 382 ACCTTCCAACATGCTGGC
M35R2............................................................................................................................ 813 GCCTGACCATAGGCTGTC
M35R3............................................................................................................................ 298 GCAAGACCTAGGTAAGTATC
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pended in 200 l of Alexa 488 (green) goat antimouse immunoglobulin G (IgG)
(Molecular Probes) diluted 1 in 200 in sterile PBS and incubated for 1 h at 37°C.
The cells were washed by centrifugation at 13,600  g for 1 min, the supernatant
removed, and the bacteria washed twice more with sterile PBS. The final sus-
pension was diluted to 1 in 20 with PBS for analysis by flow cytometry (Coulter
XL-MCL; Beckman Coulter). Approximately 100,000 cells were counted and
their relative fluorescence measured. A control for nonspecific binding of the
secondary antibody was also included.
Refolding of recombinant M35 protein. Refolding of the recombinant M35
protein was achieved by a modification of the protocol described by Watanabe
(31). Urea was removed from the protein solution by dialysis overnight against 10
mM morpholinepropanesulfonic acid, 0.1 M NaCl, 0.2% (wt/vol) sodium dodecyl
sulfate (SDS), pH 6.9. This was followed by dilution with an equal volume of the
same buffer including 20-mg/ml octylglucoside, to give a final concentration of
10-mg/ml octylglucoside. The protein was incubated at room temperature in this
solution for at least 24 h prior to sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) analysis under nonreducing conditions.
Protein gel electrophoresis and staining. Whole-cell protein samples from
each of the 18 isolates and 3 variants were subjected to one-dimensional SDS-
PAGE. Cells were grown overnight, harvested, and washed in PBS, and the
concentration was adjusted to 5  109 CFU/ml before dilution with an equal
volume of SDS reducing buffer (4.0 ml water, 1 ml 0.5 M Tris-HCl, 0.8 ml
glycerol, 1.6 ml 10% [wt/vol] SDS, 0.2 ml 0.05% [wt/vol] bromophenol blue, 50
l -mercaptoethanol). These samples were then boiled for 10 min before
electrophoresis was performed using either the Bio-Rad Mini-Protean II system
with 12% polyacrylamide gels (containing 4% polyacrylamide stacking gels) or
the Pharmacia PhastSystem with 10 to 15% gradient gels, as indicated. Gels were
then stained with Coomassie brilliant blue or silver stained.
Two-dimensional electrophoresis was also performed with whole-cell protein
samples from the K65 and ID78LN266 isolates. Cells were harvested and washed
in PBS and diluted to approximately 1.25 109 CFU/ml before sonication on ice
at an output of 40 for six 10-s bursts with 30 s between each burst, using a
probe-type sonicator (Sonifier 250; Branson Ultrasonic Corporation). An equal
volume of 20% (wt/vol) trichloroacetic acid (Mallinckrodt) was added, and the
samples were incubated on ice for 30 min. The precipitate was pelleted by
centrifugation (15,900 g) at 4°C for 15 min, and the supernatant was discarded.
The pellet was washed twice by the addition of 300 l of ice-cold acetone and
centrifuged (15,900 g) for 5 min at 4°C. The supernatant was removed, and the
pellets were left to air dry in a fume hood for approximately 30 min before
resuspension in 400 l of rehydration buffer (8.3 M urea, 1% 3-[(3-cholamido-
propyl)-dimethylammonio]-1-propanesulfonate [CHAPS], 15 mM dithiothreitol,
0.1% Biolytes 3-10 (Bio-Rad), 0.001% bromophenol blue) by sonication in a
bath-type sonicator for 1 to 2 min. The proteins were then separated by isoelec-
tric focusing (Bio-Rad IEF Cell system). This process was repeated twice for
each sample, with two different pH gradients (3 to 10 and 4 to 6). The second
dimension was performed in the same way as the one-dimensional electrophore-
sis, with the exception that the isoelectric focusing strip was embedded with
agarose embedding buffer.
Amino acid sequencing. A two-dimensional electrophoresis gel was prepared,
and the spot corresponding to the M35 protein was excised. The M35 protein was
then subjected to N-terminal amino acid sequencing at the Newcastle Protein
Facility, NSW, using Edman degradation and high-performance liquid chroma-
tography analysis.
Western blot analysis. The protein from a one-dimensional electrophoresis gel
was transferred to a nitrocellulose membrane (Bio-Rad) using a semidry tech-
nique. The gel was soaked in Tris-glycine buffer (200 mM glycine, 25 mM Tris,
pH 8.8) for 10 min before transfer to the nitrocellulose membrane between
graphite electrodes using a current that was dependent on the size of the mem-
brane (current mA  0.8  area [cm2]) for 1 h. Following transfer the nitrocel-
lulose membrane was stained with Ponceau stain and destained in distilled water
to confirm the protein transfer. It was then soaked in Tris-buffered saline (TBS)
(0.5 M NaCl, 20 mM Tris-Cl, pH 7.5) for 10 min before blocking with 1% (wt/vol)
skim milk in TBS for 30 min and washed twice with TBS containing 0.05% Tween
20 (TTBS) for 5 min before the addition of polyclonal antiserum (diluted 1/20
with 1% skim milk powder in TTBS) and left overnight with gentle agitation. The
membrane was then washed twice with TTBS for 5 min before addition of
peroxidase-conjugated antimouse IgG (Sigma Chemicals) diluted 1/500 with 1%
skim milk powder TTBS and incubated for 90 min with gentle agitation. The
membrane was washed twice more in TTBS and once in TBS for 5 min each
before being exposed to fresh HRP Developer (Bio-Rad) for approximately 1 h.
Western blot analysis for nonspecific recognition of M. catarrhalis proteins was
also performed using serum from nonimmunized mice, and no protein bands
were positive.
Nucleotide sequence accession numbers. The nucleotide sequences of the M35
genes from isolates ATCC 25240, 4223, K65, and ID78LN266 have been depos-
ited in GenBank with accession numbers AY905610, AY905611, AY905612 and
AY905613, respectively.
RESULTS
M35 gene sequence is highly conserved across 18 isolates of
M. catarrhalis. To determine the level of conservation of the
M35 gene, DNA for the homologous gene was sequenced from
18 isolates of M. catarrhalis and 3 variants (Table 1). The
isolates were chosen for their diversity based on the following
criteria: year of isolation, age group of patient, geographical
location, anatomical collection site, and the nonclumping vari-
ants of three of the clinical isolates. The latter were chosen to
ensure that this gene was not lost or varied in these isolates
that were produced as a result of passage for selection of the
“nonclumping” characteristic (19). Hence, the isolates studied
were collected at various times from the 1960s to 2001 and
from both adults and children. Our collection contained iso-
lates sent to us from both the United States and different parts
of Australia. Some were infection isolates, while others were
from commensal flora. In addition, multiple isolates from the
same original collections were used in case any variation de-
tected may have been affected by any of the selection param-
eters.
The gene comprised 1,074 bp for the full-length sequence
with a translated amino acid sequence of 358 residues (Fig. 1).
FIG. 1. Translated amino acid sequence of the M35 protein from M. catarrhalis. The K65 isolate represents the consensus, and the two
substitutions found in isolate ID78LN266 are underlined.
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There is a predicted leader sequence of 20 residues, resulting
in a mature protein of 338 residues. The sequencing of the M35
gene demonstrated that it was very highly conserved between
these 18 isolates, as well as the 3 variants. Fifteen isolates were
100% homologous, and this sequence was considered the con-
sensus. Several synonymous base changes were found in the
other six isolates. Four isolates were found to have one differ-
ence from the consensus sequence (99.9% identity), while an-
other two isolates were found to differ by four bases (99.6%
identity), and no insertions or deletions were observed.
The amino acid translations of all 21 sequences were also
compared, and this resulted in the detection of only two non-
synonymous base changes (Fig. 1). Both these amino acid
substitutions were present in isolate ID78LN266. At position
32, valine was substituted for isoleucine. Valine and isoleucine
are similar amino acids, although valine has a slightly shorter
side chain. At position 133, aspartic acid replaced glycine. This
is a replacement of a very small and uncharged amino acid with
a larger acidic residue. Since the gene was sequenced in both
directions and the sequencing process repeated, it is most
unlikely that these changes were the results of a reading error.
M35 is putatively an outer membrane porin. Submission of
the DNA sequence of the M35 gene to BLASTN returned no
significant alignments (http://www.ncbi.nlm.nih.gov/BLAST/).
However, when the translated amino acid sequence was sub-
mitted to a BLASTP database search, it revealed that M35 has
homology with many other putative porin proteins and some
known porins, including PorB from Neisseria meningitidis (3, 6,
29). An RPS-BLAST search of the conserved domain database
provided results indicating that M35 is likely to fold into struc-
tural domains similar to known gram-negative porins (18). It
was found that the amino acid sequence of M35 could be
superimposed upon that of the porin OmpC from E. coli when
similar residues were aligned. This showed an alignment of
93.8% and an Expect (E) value of 1  1017. The E value is an
indication of the statistical significance of the alignment based
upon the number of matches that would be expected by
chance, and a value less than 1  102 is generally considered
significant. Database searches also showed that the M35 se-
quence aligns with the consensus theoretical structure for
gram-negative porins with an E value of 2 108 and an
alignment of 86.9%. Included within this group of gram-neg-
ative porins are OmpF and PhoE (phosphoporin) from E. coli
(27) and osmoporin (OMP K36) (2) from Klebsiella pneu-
moniae, all of which are general outer membrane porin pro-
teins. Figure 2 shows an alignment of the translated amino acid
sequence of M35 with OMP K36 using the Cn3D program,
including the predicted positions of the two amino acid sub-
stitutions found in isolate ID78LN266. The first substitution,
valine to isoleucine, appears to be located at the base of the
periplasmic region, while the second substitution, glycine to
aspartic acid, is predicted to be located on loop 3, which folds
into the porin channel. This predicted structure is consistent
with the classical -barrel structure of bacterial outer mem-
brane porins. It has 16 antiparallel -sheets that would span
the outer membrane and are connected by 8 short periplasmic
loops and 8 longer external loops. Characteristically, each
transmembrane -sheet is composed of alternating hydropho-
bic and hydrophilic residues, so that the hydrophobic side
chains project out from the barrel into the membrane while the
hydrophilic side chains project into the lumen of the channel,
providing a hydrophilic environment within the channel allow-
ing the passage of water-soluble molecules. With this predic-
tion model, the third external loop is usually longer and is
reported to fold into the interior of the channel, restricting its
diameter and thus the size and the preference for anionic or
cationic molecules able to pass through it (18).
Porins frequently exist as trimers. To determine if M35
would form a trimer, the recombinant M35 protein was re-
folded and analyzed by SDS-PAGE. Under reducing condi-
tions, a single band was seen, with a very faint band at a higher
FIG. 2. Three-dimensional alignment of the translated M35 amino
acid sequence with OMP K36 from Klebsiella pneumoniae. Red indi-
cates residues that are identical between the two proteins, blue repre-
sents similar amino acids, and gray represents nonidentity. (A) Loca-
tion of the substitution of aspartic acid for glycine in ID78LN266
(yellow residue indicated by green arrow), viewed through the channel;
(B) location of the substitution of valine for isoleucine in ID78LN266
(yellow residue indicated by green arrow), viewed from the side with
the periplasmic region at the bottom and extracellular region at the
top; (C and D) other side views of the alignment.
FIG. 3. SDS-PAGE analysis of refolded recombinant M35 protein.
Lane A: low molecular mass protein standards, molecular masses
(kDa) as indicated; lane B: refolded M35 under reducing conditions
(with -mercaptoethanol and heated at 100°C for 5 min); lane C:
refolded M35 under nonreducing conditions (no -mercaptoethanol
and incubated at room temperature for 5 min). The arrow indicates the
faint band that corresponded to the molecular mass of a trimer of M35.
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molecular mass sometimes being evident (Fig. 3). Under non-
reducing conditions, an additional band corresponding to the
molecular mass expected of a dimer of M35 was observed,
along with a very faint band corresponding to the molecular
mass expected of the trimer of M35 (Fig. 3). Immunoblotting
with anti-M35 confirmed both the monomer and dimer but not
the faint trimer band (data not shown).
Expression and antigenic recognition of the M35 protein are
well conserved. The presence of the M35 gene in each of the
isolates evaluated is not an indication that the protein is con-
stitutively expressed by all of the strains. To confirm whether
M35 was expressed by all the strains evaluated, Western blots
were probed with anti-M35 sera. All strains were positive when
probed with anti-recombinant M35 mouse sera (Fig. 4). One
isolate (ID78LN266 in lane 3) gave a band of lower density
than the others even though the amount of bacterial protein
transferred from SDS-PAGE was equivalent. This suggests
that M35 in this strain either is expressed in smaller amounts,
is not as accessible to antibodies, or is expressed in a form that
is not as antigenically well conserved, compared to M35 from
the K65 strain and the other isolates. The Western blotting
result was confirmed by repeating the procedure on a number
of occasions.
The general SDS-PAGE profile for M. catarrhalis strains
appears highly conserved, although some minor protein band-
ing pattern differences can be observed. The protein appears
to migrate with a molecular mass of approximately 35 to 36
kDa, but the density of bands in the 30 to 40 kDa region was
too complex to assess the specific expression of the native
M35 protein. Two-dimensional electrophoresis was under-
taken to better separate M35 from other proteins of similar
molecular masses and to characterize if there were any dif-
ferences in expression between the K65 and ID78LN266
isolates.
The apparent location of M35 was predicted from both the
theoretical isoelectric point and molecular mass, which were
found to be 4.94 to 5.1 and 36.1 kDa, respectively, from cal-
culations based on the amino acid sequence using online
isoelectric point prediction programs (http://www.embl
-heidelberg.de/cgi/pi-wrapper.pl; http://us.expasy.org/tools/pi
_tool.html). The predicted position of M35 was then confirmed
by Western blotting (data not shown). The location of M35
within the two-dimensional protein profile for K65 is shown in
Fig. 5A and B. A protein spot corresponding to M35 was also
present for the ID78LN266 profile (Fig. 5C). The identity of
the spot deemed to be M35 was confirmed by N-terminal
amino acid sequencing, which produced the sequence
FIG. 4. Western blot analysis. Whole-cell protein preparations of
M. catarrhalis from different isolates were separated by SDS-PAGE,
and transferred to nitrocellulose, and probed with mouse anti-M35
sera. (A) Lane 1, prestained molecular mass markers; lane 2,
ID60LN148; lane 3, ID3LN259; lane 4, 8423; lane 5, 8402; lane 6, 8314;
lane 7, 4223; lane 8, 8361; lane 9, rM35; (B) lane 1, prestained molec-
ular mass markers; lane 2, 8724; lane 3, ID78LN266; lane 4, ATCC
25240; lane 5, 8596; lane 6, ID002LN010; lane 7, ID23LN175; lane 8,
K65.
FIG. 5. Two-dimensional electrophoresis. In the first dimension,
isolate K65 was separated across a pH gradient of (A) 3 to 10 or (B) 3
to 6, and isolate ID78LN266 was separated across a pH gradient of 3
to 6 (C). In the second dimension, SDS-PAGE-only lanes are the
following: the M. catarrhalis isolates as reference whole-cell protein
samples (isolate number) and low molecular mass markers (markers).
ve, positive; ve, negative.
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TPTVYGKAFLT, which corresponds to the first 10 amino
acids of the mature M35 protein.
The isoelectric point of M35 based on mobility on the two-
dimensional profile was estimated to be approximately 5.3,
which was marginally higher than the theoretical isoelectric
point of 4.94. It should be noted that the amino acid sequence
used to make this prediction did not include the putative
leader peptide, which corresponds to the first 20 amino acid
residues of the translated amino acid sequence (Fig. 1).
M35 is expressed on the surface of the bacterium. If M35 is
a porin, as predicted, then it should have surface-exposed re-
gions. To determine whether there were surface-exposed re-
gions of M35 that were accessible to M35-specific antisera, an
indirect immunocytometric assay was conducted. Flow cytom-
etry showed a small but reproducible curve shift between the
control cells (exposed to sera from nonimmunized mice) and
those exposed to anti-M35 sera (Fig. 6A). This demonstrated
that antibodies produced by mice against M35 bound to sur-
face-exposed regions of M. catarrhalis K65. This result shows
that antibody generated by immunization with recombinant
M35 recognized the conformational form of the native M35
and that M35 was located on the surfaces of the bacteria, as
would be expected for a porin. In contrast to the result for K65,
no curve shift was observed for strain ID78LN266 (Fig. 6B).
Hence, this would suggest that the anti-M35 that was able to
recognize M35 on the surface of K65 cells may be specific for
an epitope that includes the region where the amino acid
variation had occurred on strain ID78LN266. This was pre-
dicted to be on the surface-located loop 3.
The third external loop is immunodominant. Western blot
analysis revealed that the majority of antibodies raised against
M35 were apparently specific for loop 3. In the variant isolate,
ID78LN266, the density of the resulting band was greatly re-
duced from that observed for all other isolates (Fig. 4). The
specificity of the antibody being directed at the third loop was
confirmed by the reduction in antibody binding to a loop 3-de-
ficient recombinant M35 protein (Fig. 7).
DISCUSSION
While little is known about the mechanisms of pathogenesis
by M. catarrhalis, the focus on characterizing proteins in the
outer membrane has resulted in the elucidation of functional
roles for a number of major OMPs. OMPs described in the
literature for M. catarrhalis that have been identified as having
specific functional and/or pathogenic roles include the follow-
ing: (i) the ubiquitous surface proteins UspA1 and UspA2
(including the variant UspA2H), which have a role in cellular
adhesion and complement sensitivity (20, 22); (ii) several pro-
teins involved in the acquisition of iron, such as transferrin
binding proteins, TbpA and TbpB (21), lactoferrin binding
proteins, LbpA and LpbB (5), and a protein known as CopB
(1); and (iii) major membrane proteins, called OMPE and
OMP CD, that are highly conserved across strains (16, 25).
To date, no protein that fits a classic gram-negative porin
structure has been identified, although it has been proposed
that the OMP CD sequence is related to that of the Pseudo-
monas aeruginosa porin OprF. This relationship suggests that
perhaps OMP CD may be involved in nutrient acquisition (18,
26); however, the only evidence in support of this hypothesis is
that Omp CD mutants have lower growth rates (15). The pre-
dicted amino acid sequences for OMP CD are highly con-
FIG. 6. Flow cytometry histograms. Fluorescence curves for
(A) isolate K65 and (B) ID78LN266. The bacteria were incubated with
anti-M35 sera (unshaded curves) or nonimmune sera (shaded peaks)
and binding detected by antimouse IgG-fluorescent isothiocyanate
conjugate. The geometric mean (and median) value for fluorescence of
K65 cells exposed to anti-M35 sera were 109.12 (112.40), compared
with 55.09 (58.82) for nonimmune sera. Isolate ID78LN266 did not
demonstrate any significant curve shift, with the cells having a mean
fluorescence of 194.56 (194.56) for anti-M35 sera and 189.22 (187.60)
for the nonimmune sera.
FIG. 7. Effect on antibody recognition of M35 with a loop 3 se-
quence deletion (rM35loop3). (A) Coomassie blue-stained SDS-
PAGE showing rM35 (lane 1) and rM35loop3 (lane 2). (B) Western
blot of rM35 (lane 1) and rM35loop3 (lane 2) probed with mouse
anti-M35. (C) Western blot probed with mouse anti-M35 of isolate
K65 (lane 1) and isolate ID78LN266 (lane 2). Isolate ID78LN266
shows reduction in antibody recognition similar to observed for
rM35loop3.
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served across clinical isolates (16, 26), and this protein has
recently been shown to have adhesin properties for human
lung cells (15).
In this study we report the identification of an M. catarrhalis
protein that is characteristically typical of an outer membrane
porin (18). The protein, named M35, is the first M. catarrhalis
protein identified that fits the classic porin structure. M35 has
been identified as having potential as a vaccine candidate (13),
and this study was undertaken to do the following: (i) investi-
gate the degree of sequence conservation, (ii) determine that
the protein was expressed on the bacterial surface, and (iii)
predict the structural characteristics and possible functional
roles of M35 based on homologies to other proteins. In addi-
tion, our study has also identified a possible immunodominant
epitope.
Prediction modeling of the DNA and translated sequences
from the K65 strain suggested that M35 might be an outer
membrane porin, since its sequence shares homology with
gram-negative porins such as osmoporin (OMP K36) from
Klebsiella pneumoniae (2) and Neisseria meningitidis PorB (3, 6,
29). Typical are the 16 antiparallel membrane-spanning re-
gions comprising -sheet structures and 8 surface-exposed
loops, with loop 3 being longer, orientated into the channel,
and thought to influence the size exclusion and ion selectivity
of the porin (18). Not only did M35 meet the criteria with the
-sheet and loop regions, the predicted loop 3 section was also
a longer sequence and the modeling alignment predicted it
would fold into the pore as has been demonstrated for other
porins, such as OMP K36 from K. pneumoniae (2). Addition-
ally, in vitro refolding of the recombinant protein indicated
that M35 would form a trimer like many other porins, with
results seen in this study being consistent with those reported
by Watanabe (31) for the E. coli porin OmpF. The flow cy-
tometry results confirmed that M35 was expressed on the bac-
terial surface.
It was hypothesized that if M35 is a porin, then the pattern
of conservation in its -sheet sequence could be similar to that
of porins from other species, which tend to be highly con-
served, and the surface-exposed loop regions would be quite
variable. For example, P2 from nontypeable Haemophilus in-
fluenzae (NTHi), another gram-negative bacterium that occu-
pies the same niche in humans as M. catarrhalis, also fits a
classic porin structure and has well-conserved membrane-
spanning regions, but many of the surface-exposed loops have
variable sequence regions (4, 11). The sequencing results of the
M35 gene differ from those for these other porins in that it is
highly conserved across the entire gene in all the strains se-
quenced.
The degree of conservation of M35 is as high as, if not higher
than, that of other M. catarrhalis proteins. For example, OMP
E and CD (25, 26) are considered well enough conserved to be
suitable vaccine candidates. Their degree of conservation has
been based on restriction fragment length polymorphism,
some sequence comparisons, and the abilities of monoclonal
antibodies to bind to different strains (16, 25, 26). These pro-
teins are reported to have homologies of 95% or better be-
tween strains. Restriction fragment length polymorphism pro-
files and antibody recognition techniques can potentially
overestimate the degree of conservation due to limitations in
their ability to detect minor sequence mutations, and so se-
quencing the genes from a greater library of isolates may lower
these estimates. OMP E and CD genes have been shown to be
stable over time within the same host, remaining unchanged
over a 3- to 9- or 6-month period, respectively, when poten-
tially under selective pressure from the host’s immune system
(16, 25). Our study has differed from the approach used by
these researchers by investigating the level of genetic conser-
vation of M35 by sequencing the genes from 18 isolates of
diverse origin, as well as 3 variants. The high level of sequence
conservation of the genes in the isolates used in this study
would suggest that the M35 gene is extremely stable and may
not be a target of host immunity postinfection.
Anti-M35 produced in mice immunized with M35 strongly
recognized a single protein band within whole-cell prepara-
tions from 20 of the 21 isolates (including the 3 variants), with
the exception being isolate ID78LN266. Since the M35 expres-
sion did not appear to be reduced or lost by this strain, the
weaker Western blot result and loss of antibody recognition of
M35 on the bacterial surfaces were most likely due to a lack of
recognition of particular epitopes by the antisera. With only
two amino acid differences found between ID78LN266 and the
consensus sequence based on that from strain K65, it appeared
that the majority of M35-specific antibody may be directed
against epitopes containing these amino acids, but in particu-
lar, the substitution of aspartic acid for glycine within the third
external loop region (Fig. 2A).
While the selection of strain ID78LN266 in this study was
serendipitous, the specific amino acid mutations have provided
a means of determining that it appears that the majority of the
M35-specific antibody may be directed against an epitope on
loop 3 and that this loop was important for any surface anti-
body binding to M35. The results observed for ID78LN266
could be replicated in a loop 3-deficient recombinant M35
protein. These results could also explain why there was only a
small fluorescence curve shift when antibody bound to M35 on
the surface of M. catarrhalis, which was in contrast to a very
strong band on the Western blots. It is conceivable that in its
conformational state, loop 3 may be less accessible to antibody
if it is orientated into the channel. Support of the hypothesis
that M35 is on the bacterial surface and accessible to antibody
can be extrapolated from a recent study by Troncoso et al. that
demonstrated that M. catarrhalis produces a cross-reactive an-
tibody that recognizes N. meningitidis PorB (28). It is feasible
that this uncharacterized M. catarrhalis antigen-specific anti-
body may have been specific to M35. However, the evidence
that loop 3 of M35 is an immunodominant epitope is both
consistent with and different from reports on PorB. Studies
have reported that the PorB-specific IgG responses in conva-
lescent-phase and postimmunization sera are predominantly to
loop 1 and are marginally bactericidal but strongly opsonic
(8–10). Hence, such precedence makes it feasible that M35-
specific antibody could also be directed against a specific sur-
face loop, but unlike PorB, it appears that it may be directed
against loop 3.
Loss of antibody recognition due to a single amino acid
change in an antigen-specific loop of a porin has also been
previously demonstrated. Murphy and colleagues have shown
that point mutations resulting in a single amino acid change in
loop 5 of the NTHi porin, P2, resulted in a loss of recognition
of the epitope by a monoclonal antibody specific to this region
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(32). Such changes are believed to be part of the mechanism of
microbial evasion of host immune responses to NTHi. How-
ever, it is unlikely that similar mechanisms for sequence hy-
pervariability demonstrated by P2 and other porins are respon-
sible for the specific sequence changes found in strain
ID78LN266, since the M35 genes are so well conserved in all
the strains. It is more likely that this was a random mutation
that occurred during the evolution of this strain and happens to
be in an immunologically significant region. There was nothing
unusual or different in the clinical history of this isolate.
Hence, it will be important to investigate if individuals produce
antibody to M35 postinfection, and if so, whether this is pre-
dominantly directed against loop 3. If loop 3 is the main target,
then this may be part of an immune evasion mechanism by M.
catarrhalis. If in vivo loop 3 is folded into the porin channel,
then loop 3 would be a poor target for antibody binding and M.
catarrhalis would not be under pressure to alter the M35 se-
quence to avoid host M35-specific immune responses.
In summary, this study has identified a highly conserved
protein with a sequence that structurally meets the criteria for
that of a classic porin and hence is the first protein with a
typical porin structure to be identified for M. catarrhalis. The
protein was constitutively expressed across strains and was
detected on the bacterial surface. Our results also indicate that
loop 3 may fold into the channel and appears to be an immu-
nodominant epitope. The high degree of sequence conserva-
tion and constitutive expression would suggest that M35 may
be an excellent vaccine candidate but that the significance of
the loop 3 immunodominance on the efficacy of M35-specific
immunity should be further investigated.
ACKNOWLEDGMENTS
We acknowledge the technical assistance of Claire Batum, Ray El-
lett, Nancy Fisher, Gillian Nolen, and Peter Tyrer.
REFERENCES
1. Aebi, C., B. Stone, M. Beucher, L. D. Cope, I. Maciver, S. E. Thomas, G. H.
McCracken, Jr., P. F. Sparling, and E. J. Hansen. 1996. Expression of the
CopB outer membrane protein by Moraxella catarrhalis is regulated by iron
and affects iron acquisition from transferrin and lactoferrin. Infect. Immun.
64:2024–2030.
2. Albertı´, S., F. Rodrı´quez-Quin˜ones, T. Schirmer, G. Rummel, J. M. Toma´s,
J. P. Rosenbusch, and V. J. Benedı´. 1995. A porin from Klebsiella pneu-
moniae: sequence homology, three-dimensional model, and complement
binding. Infect. Immun. 63:903–910.
3. Bash, M. C., K. B. Leasiak, S. D. Banks, and C. E. Frasch. 1995. Analysis of
Neisseria meningitidis class 3 outer membrane protein gene variability regions
and type identification using genetic techniques. Infect. Immun. 63:1484–
1490.
4. Bell, J., S. Grass, D. Jeanteur, and R. S. Munson, Jr. 1994. Diversity of the
P2 protein among nontypeable Haemophilus influenzae isolates. Infect. Im-
mun. 62:2639–2643.
5. Bonnah, R. A., H. Wong, S. M. Loosmore, and A. B. Schryvers. 1999.
Characterization of Moraxella (Branhamella) catarrhalis lpbB, lpbA, and lac-
toferrin receptor orf3 isogenic mutants. Infect. Immun. 67:1517–1520.
6. Conceic¸a˜o, A. S. A., M. Minetti, M. S. Blake, and D. P. Remata. 1998.
Characterization of the structure, function, and conformational stability of
PorB class 3 protein from Neisseria meningitidis. J. Biol. Chem. 273:25329–
25338.
7. Daoud, A., F. Abuekteish, and H. Masaadeh. 1996. Neonatal meningitis due
to Moraxella catarrhalis and review of the literature. Ann. Trop. Paediatr.
16:199–201.
8. Delvig, A. A., T. E. Michaelsen, A. Aase, A. Hoiby, and E. Rosenqvist. 1997.
Vaccine-induced IgG antibodies to the linear epitope on the PorB outer
membrane protein promote opsonophagosis of Neisseria meningitidis by hu-
man neutrophils. Clin. Immunol. Immunopathol. 84:27–35.
9. Delvig, A. A., E. Wedege, D. A. Caugant, R. Dalseg, J. Kolberg, M. Achtman,
and E. Rosenqvist. 1995. A linear B-cell epitope on the class 3 outer-
membrane protein of Neisseria meningitidis recognized after vaccination with
the Norwegian group B outer-membrane vesicle vaccine. Microbiology 141:
1593–1600.
10. Delvig, A. A., E. Wedege, T. E. Michaelsen, A. Hoiby, P. Brandtzaeg, and E.
Rosenqvist. 1996. Immune responses to linear epitopes on the PorB protein
of Neisseria meningitidis in patients with systemic meningococcal disease.
Microbiology 142:2491–2498.
11. Duim, B., J. Dankert, H. M. Jansen, and L. van Alphen. 1993. Genetic
analysis of the diversity in outer membrane P2 of non-encapsulated Hae-
mophilus influenzae. Microb. Pathog. 14:451–462.
12. Flemingham, D., R. N. Gru¨neberg, and the Alexander Project Group. 2000.
The Alexander Project 1996–1997: latest susceptibility data from this inter-
national study of bacterial pathogens from community-acquired lower respi-
ratory tract infections. J. Antimicrob. Chemother. 45:191–203.
13. Giebink, G. S., L. O. Bakaletz, S. J. Barenkamp, B. Green, X. X. Gu, T.
Heikkinen, M. Hotomi, P. Karma, Y. Kurono, J. Kyd, T. F. Murphy, P. L.
Ogra, J. Patel, and S. Pelton. 2005. Vaccine panel. Recent advances in otitis
media. Report on the 8th Research Conference. Ann. Otol. Rhinol. Laryn-
gol. 114:86–103.
14. Hoban, D., and D. Flemingham. 2002. The PROTEKT surveillance study:
antimicrobial susceptibility of Haemophilus influenzae and Moraxella ca-
tarrhalis from community-acquired respiratory tract infections. J. Antimi-
crob. Chemother. 50:49–59.
15. Holm, M. M., S. L. Vanlerberg, I. M. Foley, D. D. Sledjeski, and E. R.
Lafontaine. 2004. The Moraxella catarrhalis porin-like outer membrane pro-
tein CD is an adhesin for human lung cells. Infect. Immun. 72:1906–1913.
16. Hsiao, C. B., S. Sethi, and T. F. Murphy. 1995. Outer membrane protein CD
of Branhamella catarrhalis: sequence conservation in strains recovered from
human respiratory tract. Microb. Pathog. 16:215–225.
17. Karalus, R., and A. Campagnari. 2000. Moraxella catarrhalis: a review of an
important human mucosal pathogen. Microbes Infect. 2:547–559.
18. Koebnik, R., K. P. Locher, and P. van Gelder. 2000. Structure and function
of bacterial outer membrane proteins: barrels in a nutshell. Mol. Microbiol.
37:239–253.
19. Kyd, J. M., A. W. Cripps, and T. F. Murphy. 1998. Outer-membrane antigen
expression by Moraxella (Branhamella) catarrhalis influences pulmonary
clearance. J. Med. Microbiol. 47:159–168.
20. Lafontaine, E. R., L. D. Cope, C. Aebi, J. L. Latimer, G. H. McCracken, Jr.,
and E. J. Hansen. 2000. The UspA1 protein and a second type of UspA2
protein mediate adherence of Moraxella catarrhalis to human epithelial cells
in vitro. J. Bacteriol. 182:1364–1373.
21. Luke, N. R., and A. A. Campagnari. 1999. Construction and characterization
of Moraxella catarrhalis mutants defective in expression of transferrin recep-
tors. Infect. Immun. 67:5815–5819.
22. Meier, P. S., R. Troller, I. N. Grivea, G. A. Syrogiannopoulos, and C. Aebi.
2002. The outer membrane proteins UspA1 and UspA2 of Moraxella ca-
tarrhalis are highly conserved in nasopharyngeal isolates from young chil-
dren. Vaccine 15:1754–1760.
23. Meyer, G. A., T. R. Shope, M. J. Waecker, and F. H. Lanningham. 1995.
Moraxella (Branhamella) catarrhalis bacteremia in children—a report of two
patients and review of the literature. Clin. Pediatr. 34:146–150.
24. Murphy, T. F. 1996. Branhamella catarrhalis—epidemiology, surface anti-
genic structure, and immune response. Microbiol. Rev. 60:267–279.
25. Murphy, T. F., A. L. Brauer, N. Yuskiw, E. R. McNamara, and C. Kirkham.
2001. Conservation of outer membrane protein E among strains of Moraxella
catarrhalis. Infect. Immun. 69:3576–3580.
26. Murphy, T. M., C. Kirkham, and A. J. Lesse. 1993. The major heat-modi-
fiable outer membrane protein CD is highly conserved among strains of
Branhamella catarrhalis. Mol. Microbiol. 10:87–97.
27. Nikaido, H. 1994. Porins and specific diffusion channels in bacterial outer
membranes. J. Biol. Chem. 269:3905–3908.
28. Troncoso, G., S. Sanchez, M. T. Criado, and C. Ferreiros. 2004. Analysis of
Moraxella catarrhalis outer membrane antigens cross-reactive with Neisseria
meningitidis and Neisseria lactamica. FEMS Immunol. Med. Microbiol. 40:
89–94.
29. van der Ley, P., J. E. Heckels, M. Virji, P. Hoogerhout, and J. T. Poolman.
1991. Topology of outer membrane porins in pathogenic Neisseria spp. In-
fect. Immun. 59:2963–2971.
30. Verduin, C. M., C. Hol, A. Fleer, H. van Dijk, and A. van Belkum. 2002.
Moraxella catarrhalis: from emerging to established pathogen. Clin. Micro-
biol. Rev. 15:125–144.
31. Watanabe, Y. 2002. Characterization of the refolding and reassembly of an
integral membrane protein OmpF porin by low-angle laser light scattering
photometry coupled with high-performance gel chromatography. J. Chro-
matogr. A 961:137–146.
32. Yi, K., and T. F. Murphy. 1994. Mapping of a strain-specific bactericidal
epitope to the surface-exposed loop 5 on the P2 porin protein of non-
typeable Haemophilus influenzae. Microb. Pathog. 17:277–282.
VOL. 187, 2005 M. CATARRHALIS PORIN PROTEIN 6535
 o
n
 O
ctober 13, 2015 by University of Queensland Library
http://jb.asm.org/
D
ow
nloaded from
 
